All Circulars (28174)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SEBI Appellate Authority dismisses RTI appeal by Rahul Sharma seeking information about a PACL plot in Mohali, upholding the respondent's … | |||||||||||||||
SEBI Appellate Authority dismisses RTI appeal by Rahul Sharma seeking information about a PACL plot in Mohali, upholding the respondent's reply that the requested information is not available with SEBI.
| |||||||||||||||
BSE notifies trading members that 14 IT sector scrips will not be available for trading in the T+0 rolling settlement cycle on Monday, May … | |||||||||||||||
BSE notifies trading members that 14 IT sector scrips will not be available for trading in the T+0 rolling settlement cycle on Monday, May 11, 2026.
| |||||||||||||||
NSE has approved Joindre Capital Services Ltd's request to surrender their membership in the Currency Derivatives including IRF segment, … | |||||||||||||||
NSE has approved Joindre Capital Services Ltd's request to surrender their membership in the Currency Derivatives including IRF segment, effective April 30, 2026.
| |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with … | |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with bidding open from May 8 to May 14, 2026 and settlement on May 21, 2026.
| |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy Acquisition Window (Delisting) for Piyush Limited, with bidding from May 12 … | |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy Acquisition Window (Delisting) for Piyush Limited, with bidding from May 12 to May 18, 2026 and settlement on May 27, 2026.
| |||||||||||||||
BSE notifies record date of 15 May 2026 for DEV LABTECH VENTURE LTD's sub-division of equity shares from Rs.10/- to Rs.5/- each and … | |||||||||||||||
BSE notifies record date of 15 May 2026 for DEV LABTECH VENTURE LTD's sub-division of equity shares from Rs.10/- to Rs.5/- each and simultaneous 1:1 bonus issue, resulting in market lot revision from 1000 to 4000.
| |||||||||||||||
BSE advises trading members to suspend dealing in commercial papers of 13 issuances across 7 companies ahead of their respective redemption … | |||||||||||||||
BSE advises trading members to suspend dealing in commercial papers of 13 issuances across 7 companies ahead of their respective redemption record dates between May 11–21, 2026.
| |||||||||||||||
NSE suspends trading in two Non-Convertible Debentures of Ugro Capital Limited effective May 12, 2026, due to maturity of the instruments. | |||||||||||||||
NSE suspends trading in two Non-Convertible Debentures of Ugro Capital Limited effective May 12, 2026, due to maturity of the instruments.
| |||||||||||||||
NSE suspends trading in four privately placed non-convertible securities effective May 08, 2026, due to redemption of instruments issued by … | |||||||||||||||
NSE suspends trading in four privately placed non-convertible securities effective May 08, 2026, due to redemption of instruments issued by Alpha Alternatives, Piramal Finance, Profectus Capital, and Muthoot Finance.
| |||||||||||||||
BSE ICCL publishes the trading and settlement schedule for the Mutual Fund segment covering subscription (liquid and non-liquid) and … | |||||||||||||||
BSE ICCL publishes the trading and settlement schedule for the Mutual Fund segment covering subscription (liquid and non-liquid) and redemption transactions for the period 01.06.2026 to 30.06.2026.
| |||||||||||||||